RENE logo

RENE EBITDA

Annual EBITDA

-$2.03 M
-$1.35 M-196.66%

December 31, 2023


Summary


Performance

RENE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENEprofitabilitymetrics:

Quarterly EBITDA

-$217.00 K
-$18.70 K-9.43%

September 30, 2024


Summary


Performance

RENE Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENEprofitabilitymetrics:

TTM EBITDA

-$1.90 M
+$1300.00+0.07%

September 30, 2024


Summary


Performance

RENE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRENEprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

RENE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-196.7%+0.6%-95.5%
3 y3 years-+9.3%-105.7%
5 y5 years-+9.3%-105.7%

RENE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-196.7%at low<-9999.0%+82.8%<-9999.0%+6.4%
5 y5-year-196.7%at low<-9999.0%+82.8%<-9999.0%+6.4%
alltimeall time-196.7%at low<-9999.0%+82.8%<-9999.0%+6.4%

Cartesian Growth Corporation II EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$217.00 K(+9.4%)
-$1.90 M(-0.1%)
Jun 2024
-
-$198.30 K(-11.2%)
-$1.90 M(-5.6%)
Mar 2024
-
-$223.20 K(-82.3%)
-$2.02 M(-0.8%)
Dec 2023
-$2.03 M
-$1.26 M(+478.7%)
-$2.03 M(+109.0%)
Sep 2023
-
-$218.30 K(-29.9%)
-$972.70 K(-3.7%)
Jun 2023
-
-$311.50 K(+30.2%)
-$1.01 M(+9.3%)
DateAnnualQuarterlyTTM
Mar 2023
-
-$239.30 K(+17.5%)
-$924.40 K(+34.9%)
Dec 2022
-$685.10 K
-$203.60 K(-20.5%)
-$685.10 K(+41.2%)
Sep 2022
-
-$256.10 K(+13.6%)
-$485.20 K(+111.8%)
Jun 2022
-
-$225.40 K(<-9900.0%)
-$229.10 K(+6091.9%)
Mar 2022
-
$0.00(-100.0%)
-$3700.00(0.0%)
Dec 2021
-
-$3700.00
-$3700.00

FAQ

  • What is Cartesian Growth Corporation II annual EBITDA?
  • What is the all time high annual EBITDA for Cartesian Growth Corporation II?
  • What is Cartesian Growth Corporation II annual EBITDA year-on-year change?
  • What is Cartesian Growth Corporation II quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Cartesian Growth Corporation II?
  • What is Cartesian Growth Corporation II quarterly EBITDA year-on-year change?
  • What is Cartesian Growth Corporation II TTM EBITDA?
  • What is the all time high TTM EBITDA for Cartesian Growth Corporation II?
  • What is Cartesian Growth Corporation II TTM EBITDA year-on-year change?

What is Cartesian Growth Corporation II annual EBITDA?

The current annual EBITDA of RENE is -$2.03 M

What is the all time high annual EBITDA for Cartesian Growth Corporation II?

Cartesian Growth Corporation II all-time high annual EBITDA is -$685.10 K

What is Cartesian Growth Corporation II annual EBITDA year-on-year change?

Over the past year, RENE annual EBITDA has changed by -$1.35 M (-196.66%)

What is Cartesian Growth Corporation II quarterly EBITDA?

The current quarterly EBITDA of RENE is -$217.00 K

What is the all time high quarterly EBITDA for Cartesian Growth Corporation II?

Cartesian Growth Corporation II all-time high quarterly EBITDA is $0.00

What is Cartesian Growth Corporation II quarterly EBITDA year-on-year change?

Over the past year, RENE quarterly EBITDA has changed by +$1300.00 (+0.60%)

What is Cartesian Growth Corporation II TTM EBITDA?

The current TTM EBITDA of RENE is -$1.90 M

What is the all time high TTM EBITDA for Cartesian Growth Corporation II?

Cartesian Growth Corporation II all-time high TTM EBITDA is -$3700.00

What is Cartesian Growth Corporation II TTM EBITDA year-on-year change?

Over the past year, RENE TTM EBITDA has changed by -$929.20 K (-95.53%)